Search

Meena A. Chelliah

Examiner (ID: 16847)

Most Active Art Unit
2204
Art Unit(s)
3641, 1612, 2204, 2899
Total Applications
790
Issued Applications
755
Pending Applications
11
Abandoned Applications
24

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19187775 [patent_doc_number] => 20240166688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => NOVEL USE OF PEPTIDE FOR INHIBITING FUNCTIONS AND EXPRESSIONS OF MULTIPLE DISEASE BIOMARKERS [patent_app_type] => utility [patent_app_number] => 18/385640 [patent_app_country] => US [patent_app_date] => 2023-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7507 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18385640 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/385640
Use of peptide for inhibiting functions and expressions of multiple disease biomarkers Oct 30, 2023 Issued
Array ( [id] => 19032558 [patent_doc_number] => 20240082373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => COMPOSITIONS FOR CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/339230 [patent_app_country] => US [patent_app_date] => 2023-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38252 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18339230 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/339230
COMPOSITIONS FOR CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY AND USES THEREOF Jun 20, 2023 Pending
Array ( [id] => 19049394 [patent_doc_number] => 20240091363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => A SENSITIZER- PEPTIDE CONJUGATE [patent_app_type] => utility [patent_app_number] => 18/329523 [patent_app_country] => US [patent_app_date] => 2023-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10974 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18329523 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/329523
A SENSITIZER- PEPTIDE CONJUGATE Jun 4, 2023 Pending
Array ( [id] => 18806940 [patent_doc_number] => 20230381273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => NANOPARTICLE IN WHICH ANTIBACTERIAL PEPTIDE IS ENCAPSULATED WITH CHITOSAN AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/298798 [patent_app_country] => US [patent_app_date] => 2023-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10602 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18298798 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/298798
NANOPARTICLE IN WHICH ANTIBACTERIAL PEPTIDE IS ENCAPSULATED WITH CHITOSAN AND USE THEREOF Apr 10, 2023 Pending
Array ( [id] => 18806940 [patent_doc_number] => 20230381273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => NANOPARTICLE IN WHICH ANTIBACTERIAL PEPTIDE IS ENCAPSULATED WITH CHITOSAN AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/298798 [patent_app_country] => US [patent_app_date] => 2023-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10602 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18298798 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/298798
NANOPARTICLE IN WHICH ANTIBACTERIAL PEPTIDE IS ENCAPSULATED WITH CHITOSAN AND USE THEREOF Apr 10, 2023 Pending
Array ( [id] => 18647650 [patent_doc_number] => 20230293420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES [patent_app_type] => utility [patent_app_number] => 18/296032 [patent_app_country] => US [patent_app_date] => 2023-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2922 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296032 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/296032
COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES Apr 4, 2023 Abandoned
Array ( [id] => 18647650 [patent_doc_number] => 20230293420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES [patent_app_type] => utility [patent_app_number] => 18/296032 [patent_app_country] => US [patent_app_date] => 2023-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2922 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296032 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/296032
COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES Apr 4, 2023 Abandoned
Array ( [id] => 18647650 [patent_doc_number] => 20230293420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES [patent_app_type] => utility [patent_app_number] => 18/296032 [patent_app_country] => US [patent_app_date] => 2023-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2922 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296032 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/296032
COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES Apr 4, 2023 Abandoned
Array ( [id] => 18692563 [patent_doc_number] => 20230322861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => SYNTHETIC PEPTIDES FOR DISSOLVING TAU INCLUSIONS [patent_app_type] => utility [patent_app_number] => 18/124252 [patent_app_country] => US [patent_app_date] => 2023-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3754 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18124252 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/124252
SYNTHETIC PEPTIDES FOR DISSOLVING TAU INCLUSIONS Mar 20, 2023 Pending
Array ( [id] => 18649421 [patent_doc_number] => 20230295231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa [patent_app_type] => utility [patent_app_number] => 18/178143 [patent_app_country] => US [patent_app_date] => 2023-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11937 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18178143 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/178143
Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa Mar 2, 2023 Pending
Array ( [id] => 18649421 [patent_doc_number] => 20230295231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa [patent_app_type] => utility [patent_app_number] => 18/178143 [patent_app_country] => US [patent_app_date] => 2023-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11937 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18178143 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/178143
Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa Mar 2, 2023 Pending
Array ( [id] => 18737972 [patent_doc_number] => 20230346874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/107640 [patent_app_country] => US [patent_app_date] => 2023-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19915 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18107640 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/107640
METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS Feb 8, 2023 Pending
Array ( [id] => 18582879 [patent_doc_number] => 20230265136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => USE OF CNPY3 PROTEIN AS TARGET FOR TREATING OF DENGUE FEVER [patent_app_type] => utility [patent_app_number] => 18/063499 [patent_app_country] => US [patent_app_date] => 2022-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6128 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063499 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/063499
USE OF CNPY3 PROTEIN AS TARGET FOR TREATING OF DENGUE FEVER Dec 7, 2022 Pending
Array ( [id] => 18497408 [patent_doc_number] => 20230220038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => BRI2 BRICHOS DOMAIN FOR DELIVERY OF PROTEINS INTO CNS NEURONS [patent_app_type] => utility [patent_app_number] => 18/046138 [patent_app_country] => US [patent_app_date] => 2022-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23632 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046138 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/046138
BRI2 BRICHOS DOMAIN FOR DELIVERY OF PROTEINS INTO CNS NEURONS Oct 11, 2022 Pending
Array ( [id] => 18179865 [patent_doc_number] => 20230040594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => MILK-DERIVED POLYPEPTIDE DERIVATIVE, COMPOSITION AND METHOD FOR PREVENTING AND TREATING OBESITY [patent_app_type] => utility [patent_app_number] => 17/812138 [patent_app_country] => US [patent_app_date] => 2022-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4010 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812138 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/812138
MILK-DERIVED POLYPEPTIDE DERIVATIVE, COMPOSITION AND METHOD FOR PREVENTING AND TREATING OBESITY Jul 11, 2022 Pending
Array ( [id] => 18179865 [patent_doc_number] => 20230040594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => MILK-DERIVED POLYPEPTIDE DERIVATIVE, COMPOSITION AND METHOD FOR PREVENTING AND TREATING OBESITY [patent_app_type] => utility [patent_app_number] => 17/812138 [patent_app_country] => US [patent_app_date] => 2022-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4010 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812138 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/812138
MILK-DERIVED POLYPEPTIDE DERIVATIVE, COMPOSITION AND METHOD FOR PREVENTING AND TREATING OBESITY Jul 11, 2022 Pending
Array ( [id] => 17881200 [patent_doc_number] => 20220296677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => PEPTIDE SCYREPROCIN OF SCYLLA PARAMAMOSAIN AND METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/747360 [patent_app_country] => US [patent_app_date] => 2022-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3250 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747360 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/747360
PEPTIDE SCYREPROCIN OF SCYLLA PARAMAMOSAIN AND METHOD THEREOF May 17, 2022 Pending
Array ( [id] => 20272000 [patent_doc_number] => 12441769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-14 [patent_title] => Polypeptide, photoresist composition including the same, and method of forming pattern using the same [patent_app_type] => utility [patent_app_number] => 17/741590 [patent_app_country] => US [patent_app_date] => 2022-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3834 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 293 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17741590 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/741590
Polypeptide, photoresist composition including the same, and method of forming pattern using the same May 10, 2022 Issued
Array ( [id] => 18003552 [patent_doc_number] => 20220362318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => METHOD FOR TREATMENT OF PSORIASIS [patent_app_type] => utility [patent_app_number] => 17/662989 [patent_app_country] => US [patent_app_date] => 2022-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4618 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662989 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/662989
METHOD FOR TREATMENT OF PSORIASIS May 10, 2022 Pending
Array ( [id] => 18003552 [patent_doc_number] => 20220362318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => METHOD FOR TREATMENT OF PSORIASIS [patent_app_type] => utility [patent_app_number] => 17/662989 [patent_app_country] => US [patent_app_date] => 2022-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4618 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662989 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/662989
METHOD FOR TREATMENT OF PSORIASIS May 10, 2022 Pending
Menu